OmicsChart
OmicsChart offers a platform that lets translational cancer researchers analyze multi-omics and clinical data to discover biomarkers and validate real-world findings. It does this via PREON, a software-enabled platform built on federated data integration, de-identified patient records, machine learning, and biologist-friendly visualizations to support exploratory and hypothesis-driven workflows. The company supports NGS, genomics, transcriptomics, proteomics, and single-cell analyses and combines software with domain-specific consulting and scientific software development. Integrations and services include data harmonization from public and proprietary sources, data warehousing design, and pipeline/dashboard development for research teams. OmicsChart primarily serves translational researchers and biopharmaceutical organizations working on precision oncology research.
OmicsChart
OmicsChart offers a platform that lets translational cancer researchers analyze multi-omics and clinical data to discover biomarkers and validate real-world findings. It does this via PREON, a software-enabled platform built on federated data integration, de-identified patient records, machine learning, and biologist-friendly visualizations to support exploratory and hypothesis-driven workflows. The company supports NGS, genomics, transcriptomics, proteomics, and single-cell analyses and combines software with domain-specific consulting and scientific software development. Integrations and services include data harmonization from public and proprietary sources, data warehousing design, and pipeline/dashboard development for research teams. OmicsChart primarily serves translational researchers and biopharmaceutical organizations working on precision oncology research.
TL;DR
Headquarters: Cardiff, United Kingdom
Product: PREON — patient-centric cancer data & analytics platform (24,000+ de-identified records)
Founders: Tanya Aneichyk; Asta Proctor
Focus: Translational cancer research, multi-omics & real-world data
Founded: 2022
Company Overview
Problem Domain
Translational oncology research and biomarker discovery from multi-omics and real-world clinical data.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
317361 USD
Public profiles list participation in accelerators (Techstars, PharmStars) and non-equity assistance; Crunchbase records non-equity assistance as most recent financing type.
Investor Signal
“PharmStars; Techstars; Debiopharm Innovation Fund”